首页> 外文期刊>The Journal of Alternative and Complementary Medicine >Safety and Tolerability of an Antiasthma Herbal Formula (ASHMI™) in Adult Subjects with Asthma: A Randomized, Double-Blinded, Placebo-Controlled, Dose-Escalation Phase I Study
【24h】

Safety and Tolerability of an Antiasthma Herbal Formula (ASHMI™) in Adult Subjects with Asthma: A Randomized, Double-Blinded, Placebo-Controlled, Dose-Escalation Phase I Study

机译:成人哮喘患者中抗哮喘草药配方(ASHMI™)的安全性和耐受性:一项随机,双盲,安慰剂对照,剂量递增的I期研究

获取原文
获取原文并翻译 | 示例
           

摘要

Conclusion: In this phase I study, ASHMI appeared to be safe and well tolerated by subjects with asthma. These findings allowed initiation of a larger phase II study to assess the efficacy of ASHMI.
机译:结论:在这一阶段的研究中,ASHMI似乎是安全的,并且对哮喘患者耐受良好。这些发现允许开展更大的II期研究以评估ASHMI的疗效。

著录项

  • 来源
  • 作者单位

    Division of Pediatric Pulmonary Medicine, Columbia University, New York, NY.;

    Division of Pediatric Allergy and Immunology, Mount Sinai School of Medicine, New York, NY.;

    Division of Adult Allergy and Immunology, Mount Sinai School of Medicine, New York, NY.;

    Division of Pediatric Allergy and Immunology, Mount Sinai School of Medicine, New York, NY.;

    Division of Pediatric Allergy and Immunology, Mount Sinai School of Medicine, New York, NY.;

    Division of Pediatric Allergy and Immunology, Mount Sinai School of Medicine, New York, NY.;

    Division of General Internal Medicine and Pulmonary, Critical Care, and Sleep Medicine, Mount Sinai School of Medicine, New York, NY.;

    Division of Pediatric Pulmonary Medicine, Columbia University, New York, NY.;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号